Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
4,52 USD | 0,00 % | 0,00 % | -30,99 % |
Resumen de negocios
Número de empleados: 67
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Proprietary Prodrugs
100,0
%
| 10 | 100,0 % | 27 | 100,0 % | +162,58 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States and Europe
100,0
%
| 10 | 100,0 % | 27 | 100,0 % | +162,58 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Christal Mickle
FOU | Founder | 45 | 30/10/06 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 10/10/23 |
R. Clifton
DFI | Director of Finance/CFO | 51 | 01/04/15 |
Daniel Gallo
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/23 |
Adrian Quartel
CTO | Chief Tech/Sci/R&D Officer | 63 | 04/01 |
Sven Guenther
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/01/07 |
Nichol Ochsner
IRC | Investor Relations Contact | - | 09/08/22 |
Abbi Maher
LAW | General Counsel | - | 31/01/23 |
Joshua Schafer
PRN | Corporate Officer/Principal | 53 | 09/01/23 |
Comptroller/Controller/Auditor | 40 | 13/02/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 25/04/23 |
Tamara Favorito
CHM | Chairman | 65 | 18/08/21 |
Director/Board Member | 56 | 25/04/23 | |
Christal Mickle
FOU | Founder | 45 | 30/10/06 |
Sven Guenther
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/01/07 |
Corey Watton
BRD | Director/Board Member | 54 | 25/04/23 |
John Bode
BRD | Director/Board Member | 49 | 25/04/23 |
Thomas Anderson
BRD | Director/Board Member | 68 | 07/08/23 |
Alvin Shih
BRD | Director/Board Member | 47 | 20/01 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 10/10/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 45 001 878 | 39 916 898 ( 88,70 %) | 1 575 692 ( 3,501 %) | 88,70 % |
Información de la empresa
Zevra Therapeutics, Inc.
1180 Celebration Boulevard Suite 103
34747, Celebration
+321 939 3416
http://zevra.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-30,99 % | 189 M | |
+5,31 % | 70,44 mil M | |
+10,97 % | 8939,13 M | |
-16,83 % | 4750,81 M | |
+43,48 % | 4497,76 M | |
+3,20 % | 3845,87 M | |
-21,36 % | 2341,22 M | |
-29,67 % | 2196,26 M | |
+8,38 % | 1963,71 M | |
+3,90 % | 1645,88 M |
- Bolsa de valores
- Acciones
- Acción ZVRA
- Empresa Zevra Therapeutics, Inc.